Sanofi-Synthelabo is a major global research-based pharmaceutical group with 32,500 employees in more than 100 countries and consolidated sales of over euro 8 billion in 2003. With an R&D portfolio of 55 compounds in development, Sanofi-Synthelabo is focused on a core group of four therapeutic areas: cardiovascular disease and thrombosis; diseases of the central nervous system; internal medicine; and oncology.
View Top Employees from Sanofi-Synthelabo SA| Website | http://www.sanofi-synthelabo.com |
| Revenue | $84.4 million |
| Employees | 2 (2 on RocketReach) |
| Address | 9 Great Valley Pkwy, Malvern, Pennsylvania 19355, US |
| Phone | (610) 889-8600 |
| Industry | Drug Manufacturing & Research, Pharmaceuticals, Healthcare |
| Competitors | Adcock Ingram Critical Care (Pty) Ltd., Helsinn Group, Morepen Laboratories Limited India, Pharma Science Inc, Recordati |
| SIC | SIC Code 2834 Companies, SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 446 Companies, NAICS Code 325 Companies, NAICS Code 44 Companies |
Looking for a particular Sanofi-Synthelabo SA employee's phone or email?
Sanofi-Synthelabo SA Questions
The Sanofi-Synthelabo SA annual revenue was $84.4 million in 2023.
2 people are employed at Sanofi-Synthelabo SA.
Sanofi-Synthelabo SA is based in Malvern, Pennsylvania.
The NAICS codes for Sanofi-Synthelabo SA are [3254, 32, 32541, 446, 325, 44].
The SIC codes for Sanofi-Synthelabo SA are [2834, 28, 283].
